Under the agreement, the two companies will jointly undertake co-development of a multi-year pipeline of high-value specialty ...

The pharmaceutical CMO market thrives on increased outsourcing due to strategic realignment and advanced therapy approvals. Expanding in Asia-Pacific and integrated service offerings further drive ...

Agno Pharma, a global contract development and manufacturing organization (CDMO) specializing in small-molecule active ...

In just three months, Phlow and Enveda generated and analyzed nearly 20,000 unique reactions, creating one of the largest high-quality datasets of its kind. The resulting uniform dataset is ...

EAST RUTHERFORD, N.J., Oct. 22, 2025 /PRNewswire/ -- Cambrex, a leading global contract development and manufacturing organization (CDMO), today announced a $120 million investment to expand its U.S.

Enveda has been using AI to power its drug discovery platform for several years. The company injected $230 million into ...

Amid shortages of cancer drugs in the U.S., the API Innovation Center will use continuous manufacturing technology and a partnership with Apertus Pharmaceuticals and the Glioblastoma Foundation to ...

“Our customers, in partnership with federal and state agencies, are reshoring drug manufacturing in the U.S., the world’s largest pharmaceutical market. Local API production is vital for supply chain ...

Saharsh Davuluri, Neuland Labs, urges API and peptide automation by 2026 to match modern biologics standards.

Eli Lilly has unveiled the location of the third of its four large-scale manufacturing facilities that it plans to build in the U.S. The drugmaker has selected Huntsville, Alabama, as the site of a $6 ...

HAMBURG, GERMANY / ACCESSWIRE / November 5, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) has announced the sale of its chemical API manufacturing site, ...